Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Receipt of final approval by our subsidiary, Caplin Steriles Limited, from the USFDA for Foscarnet Sodium Injection.".
Press Release May 14 2026
Filed with NSE · · 3 pages · English
Release
Caplin Point Laboratories Limited on 6ix
Earlier from Caplin Point Laboratories
- Press Release May 05 2026
- Press Release Mar 13 2026
- Press Release Feb 28 2026
- Press Release Feb 24 2026
- Press Release Jan 27 2026
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories